Street Calls of the Week
WESTBROOK, Maine - Synergy CHC Corp. (NASDAQ:SNYR), a $26.3 million market cap company with impressive gross profit margins of 70%, announced Wednesday a distribution partnership with AlaBev to expand retail availability of its FOCUSfactor Focus + Energy beverages and brain-health energy shots across Alabama.
The agreement will place FOCUSfactor products in more than 5,000 grocery, convenience, and specialty retailers throughout the state, according to a company press release.
AlaBev, which has nearly 120 years of experience in beverage distribution, operates three warehouses across Alabama and will provide direct-store-delivery services for the cognitive performance products.
"AlaBev is a proven distributor with deep roots in Alabama, a stellar reputation for execution, and a strong track record of scaling brands across the Southeast," said Jack Ross, CEO of Synergy CHC Corp.
Michael Silinsky, CFO of AlaBev, stated that FOCUSfactor "stands out in the rapidly growing functional beverage category" and that the company looks forward to bringing the products to retail partners across Alabama.
The partnership represents part of Synergy’s broader Southeast expansion strategy for its FOCUSfactor brand, which includes supplements and functional beverages marketed for cognitive performance and brain health.
Synergy CHC Corp. also owns the Flat Tummy brand, which focuses on women’s wellness and weight management products. The company’s FOCUSfactor products are currently distributed through retailers including Costco, Walmart, Amazon, BJ’s, and Walgreens.
The company indicated it plans to announce additional retail partnerships and distribution deals in the coming months. Trading at an attractive P/E ratio of 5.54x and receiving a Strong Buy consensus from analysts, SNYR shows promising potential. Get comprehensive analysis and Fair Value estimates with a InvestingPro subscription, which includes detailed research reports for over 1,400 US stocks.
In other recent news, Synergy CHC Corporation reported strong financial results for the second quarter of 2025. The company achieved a 125% increase in net income year-over-year, with net revenue reaching $8.1 million, representing a 1% rise. These results highlight the company’s profitability growth and strategic expansions. Additionally, Synergy CHC announced the pricing of an underwritten public offering of 1,750,000 shares of common stock at $2.50 per share, aiming to generate gross proceeds of $4.375 million. The company has also provided underwriters with a 45-day option to purchase up to an additional 262,500 shares. Despite a slight dip in stock price during pre-market trading, the company remains focused on future growth, particularly with its planned international expansions. These recent developments are part of Synergy CHC’s ongoing efforts to strengthen its market position and financial performance.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.